UNRESECTABLE LEIOMYOSARCOMA
Clinical trials for UNRESECTABLE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for rare sarcomas
Disease control OngoingThis study tests whether combining two drugs, cabozantinib and temozolomide, can help people with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. About 96 adults with leiomyosarcoma or other similar sarcomas will take part. The goal is to see if the …
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 05:26 UTC
-
New drug cocktail shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the drug cabozantinib to a standard immunotherapy combination (ipilimumab and nivolumab) works better than immunotherapy alone for people with advanced soft tissue sarcoma. About 66 adults with specific sarcoma types that have spread or cannot be r…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated May 11, 2026 20:46 UTC